|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Sir Andrew Witty
|
|
|
b)
|
Position/status
|
Chief Executive Officer
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in Ordinary Shares following the
re-investment of dividends paid to shareholders on 13 October 2016
on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus
Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.00
|
370.567 (personal contribution)
|
||
|
£17.00
|
370.555 (personal contribution)
|
||
|
£17.00
|
185.720 (personal contribution
|
||
|
£17.00
|
185.720 (personal contribution)
|
||
|
£17.00
|
465.257 (personal contribution)
|
||
|
£17.00
|
370.567 (matching shares)
|
||
|
£17.00
|
370.555 (matching shares)
|
||
|
£17.00
|
185.720 (matching shares)
|
||
|
£17.00
|
185.720(matching shares)
|
||
|
£17.00
|
465.257 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
3155.638
£17.00
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Ms E Walmsley
|
|
|
b)
|
Position/status
|
CEO Designate
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in Ordinary Shares following the
re-investment of dividends paid to shareholders on 13 October 2016
on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus
Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.00
|
81.138 (personal contribution)
|
||
|
£17.00
|
81.138 (personal contribution)
|
||
|
£17.00
|
64.694 (personal contribution)
|
||
|
£17.00
|
64.694 (personal contribution)
|
||
|
£17.00
|
160.210 (personal contribution)
|
||
|
£17.00
|
160.199 (personal contribution)
|
||
|
£17.00
|
81.138 (matching shares)
|
||
|
£17.00
|
81.138 (matching shares)
|
||
|
£17.00
|
64.694 (matching shares)
|
||
|
£17.00
|
64.694 (matching shares)
|
||
|
£17.00
|
160.210 (matching shares)
|
||
|
£17.00
|
160.199 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
1224.146
£17.00
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Mr R G Connor
|
|
|
b)
|
Position/status
|
President, Global Manufacturing & Supply
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in Ordinary Shares following the
re-investment of dividends paid to shareholders on 13 October 2016
on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus
Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.00
|
72.533 (personal contribution)
|
||
|
£17.00
|
72.521 (personal contribution)
|
||
|
£17.00
|
47.378 (personal contribution)
|
||
|
£17.00
|
47.378 (personal contribution)
|
||
|
£17.00
|
108.850 (personal contribution)
|
||
|
£17.00
|
72.533 (matching shares)
|
||
|
£17.00
|
72.521 (matching shares)
|
||
|
£17.00
|
47.378 (matching shares)
|
||
|
£17.00
|
47.378 (matching shares)
|
||
|
£17.00
|
108.850 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
697.320
£17.00
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Mr S Dingemans
|
|
|
b)
|
Position/status
|
Chief Financial Officer
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in Ordinary Shares following the
re-investment of dividends paid to shareholders on 13 October 2016
on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus
Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.00
|
175.105 (personal contribution)
|
||
|
£17.00
|
70.032 (personal contribution)
|
||
|
£17.00
|
90.364 (personal contribution)
|
||
|
£17.00
|
90.352 (personal contribution)
|
||
|
£17.00
|
211.571 (personal contribution)
|
||
|
£17.00
|
211.560 (personal contribution)
|
||
|
£17.00
|
175.105 (matching shares)
|
||
|
£17.00
|
70.032 (matching shares)
|
||
|
£17.00
|
90.364 (matching shares)
|
||
|
£17.00
|
90.352 (matching shares)
|
||
|
£17.00
|
211.571 (matching shares)
|
||
|
£17.00
|
211.560 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
1697.968
£17.00
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Mr N Hirons
|
|
|
b)
|
Position/status
|
SVP, Global Ethics & Compliance
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in Ordinary Shares following the
re-investment of dividends paid to shareholders on 13 October 2016
on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus
Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.00
|
33.172 (personal contribution)
|
||
|
£17.00
|
33.172 (personal contribution)
|
||
|
£17.00
|
78.227 (personal contribution)
|
||
|
£17.00
|
78.227 (personal contribution)
|
||
|
£17.00
|
33.172 (matching shares)
|
||
|
£17.00
|
33.172 (matching shares)
|
||
|
£17.00
|
78.227 (matching shares)
|
||
|
£17.00
|
78.227 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
445.596
£17.00
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Mr S A Hussain
|
|
|
b)
|
Position/status
|
President, Global Pharmaceuticals
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in Ordinary Shares following the
re-investment of dividends paid to shareholders on 13 October 2016
on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus
Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.00
|
106.388 (personal contribution)
|
||
|
£17.00
|
156.376 (personal contribution)
|
||
|
£17.00
|
184.855 (personal contribution)
|
||
|
£17.00
|
184.855 (personal contribution)
|
||
|
£17.00
|
106.388(matching shares)
|
||
|
£17.00
|
156.376 (matching shares)
|
||
|
£17.00
|
184.855 (matching shares)
|
||
|
£17.00
|
184.855 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
1264.948
£17.00
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Mr D S Redfern
|
|
|
b)
|
Position/status
|
Chief Strategy Officer
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in Ordinary Shares following the
re-investment of dividends paid to shareholders on 13 October 2016
on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus
Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.00
|
66.155 (personal contribution)
|
||
|
£17.00
|
66.142 (personal contribution)
|
||
|
£17.00
|
53.158 (personal contribution)
|
||
|
£17.00
|
53.158 (personal contribution)
|
||
|
£17.00
|
99.557 (personal contribution)
|
||
|
£17.00
|
99.557 (personal contribution)
|
||
|
£17.00
|
66.155 (matching shares)
|
||
|
£17.00
|
66.142 (matching shares)
|
||
|
£17.00
|
53.158 (matching shares)
|
||
|
£17.00
|
53.158 (matching shares)
|
||
|
£17.00
|
99.557 (matching shares)
|
||
|
£17.00
|
99.557 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
875.454
£17.00
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Dr M M Slaoui
|
|
|
b)
|
Position/status
|
Chairman, Global Vaccines
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W1053
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in ADSs following the re-investment
of dividends paid to shareholders on 13 October 2016 on ADSs held
in the Company's 2009 Deferred Annual Bonus Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
$42.39
|
115.213 (personal contribution)
|
||
|
$42.39
|
115.202 (personal contribution)
|
||
|
$42.39
|
71.742 (personal contribution)
|
||
|
$42.39
|
71.742 (personal contribution)
|
||
|
$42.39
|
118.095 (personal contribution)
|
||
|
$42.39
|
118.095 (personal contribution)
|
||
|
$42.39
|
115.213 (matching shares)
|
||
|
$42.39
|
115.202 (matching shares)
|
||
|
$42.39
|
71.742 (matching shares)
|
||
|
$42.39
|
71.742 (matching shares)
|
||
|
$42.39
|
118.095 (matching shares)
|
||
|
$42.39
|
118.095 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
1220.178
$42.39
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Ms C Thomas
|
|
|
b)
|
Position/status
|
SVP, Human Resources
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in Ordinary Shares following the
re-investment of dividends paid to shareholders on 13 October 2016
on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus
Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.00
|
82.083 (personal contribution)
|
||
|
£17.00
|
71.552 (personal contribution)
|
||
|
£17.00
|
71.540 (personal contribution)
|
||
|
£17.00
|
145.649 (personal contribution)
|
||
|
£17.00
|
145.649 (personal contribution)
|
||
|
£17.00
|
82.083 (matching shares)
|
||
|
£17.00
|
71.552 (matching shares)
|
||
|
£17.00
|
71.540 (matching shares)
|
||
|
£17.00
|
145.649 (matching shares)
|
||
|
£17.00
|
145.649 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
1032.946
£17.00
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Mr P C Thomson
|
|
|
b)
|
Position/status
|
SVP, Communications & Government Affairs
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in Ordinary Shares following the
re-investment of dividends paid to shareholders on 13 October 2016
on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus
Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.00
|
49.436 (personal contribution)
|
||
|
£17.00
|
48.598 (personal contribution)
|
||
|
£17.00
|
89.112 (personal contribution)
|
||
|
£17.00
|
49.436 (matching shares)
|
||
|
£17.00
|
48.598 (matching shares)
|
||
|
£17.00
|
89.112 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
374.292
£17.00
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Mr D E Troy
|
|
|
b)
|
Position/status
|
SVP & General Counsel
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
American Depositary Shares ('ADSs')
ISIN: US37733W1053
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in ADSs following the re-investment
of dividends paid to shareholders on 13 October 2016 on ADSs held
in the Company's 2009 Deferred Annual Bonus Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
$42.39
|
46.628 (personal contribution)
|
||
|
$42.39
|
46.628 (personal contribution)
|
||
|
$42.39
|
37.123 (personal contribution)
|
||
|
$42.39
|
37.123 (personal contribution)
|
||
|
$42.39
|
83.585 (personal contribution)
|
||
|
$42.39
|
83.585 (personal contribution)
|
||
|
$42.39
|
46.628 (matching shares)
|
||
|
$42.39
|
46.628 (matching shares)
|
||
|
$42.39
|
37.123 (matching shares)
|
||
|
$42.39
|
37.123 (matching shares)
|
||
|
$42.39
|
83.585 (matching shares)
|
||
|
$42.39
|
83.585 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
669.344
$42.39
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|
|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
||
|
a)
|
Name
|
Dr P J T Vallance
|
|
|
b)
|
Position/status
|
President, Pharmaceuticals R&D
|
|
|
c)
|
Initial
notification/
amendment
|
Initial notification
|
|
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
GlaxoSmithKline plc
|
|
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
|
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
||
|
a)
|
Description
of the financial instrument
|
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN:
GB0009252882
|
|
|
b)
|
Nature
of the transaction
|
Increase in notional interest in Ordinary Shares following the
re-investment of dividends paid to shareholders on 13 October 2016
on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus
Plan.
|
|
|
c)
|
Price(s)
and volume(s)
|
Price(s)
|
Volume(s)
|
|
£17.00
|
146.682 (personal contribution)
|
||
|
£17.00
|
146.671 (personal contribution)
|
||
|
£17.00
|
105.324 (personal contribution)
|
||
|
£17.00
|
105.324 (personal contribution)
|
||
|
£17.00
|
171.329 (personal contribution)
|
||
|
£17.00
|
171.329 (personal contribution)
|
||
|
£17.00
|
146.682 (matching shares)
|
||
|
£17.00
|
146.671 (matching shares)
|
||
|
£17.00
|
105.324 (matching shares)
|
||
|
£17.00
|
105.324 (matching shares)
|
||
|
£17.00
|
171.329 (matching shares)
|
||
|
£17.00
|
171.329 (matching shares)
|
||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
1693.318
£17.00
|
|
|
e)
|
Date
of the transaction
|
2016-10-13
|
|
|
f)
|
Place
of the transaction
|
n/a
|
|